Advocates of drug law reform had reason to celebrate today after public statements by senior figures in the medical and legal community suggested the argument was turning in their favour.
The chair of the Bar Council argued in his most recent report that decriminalising drug use would have substantial public benefits, while the editor of the British Medical Journal (BMJ), the UK's most well-respected medical publication, came out publicly in support of drug law reform.
The twin developments come at an exciting time for those calling for a more liberal drug policy. Both deputy prime minister Nick Clegg and prime minister David Cameron are on record questioning the effectiveness of Britain's drug laws. Activists hope reform might be in the pipeline.
In his most recent report the chair of the Bar Council, Nicholas Green QC, argued that decriminalising drugs did not lead to greater use and would have the effect of cutting crime.
"A growing body of comparative evidence suggests that decriminalising personal use can have positive consequences; it can free up huge amounts of police resources, reduce crime and recidivism and improve public health," he said.
"All this can be achieved without any overall increase in drug usage. If this is so, then it would be rational to follow suit. And this will save money and mean that there is less pressure on the justice system.
"A rational approach is not usually the response of large parts of the media when it comes to issues relating to criminal justice," he continued.
"This is something the Bar Council can address. We are apolitical; we act for the prosecution and the defence and most of the judiciary are former members. We can speak out in favour of an approach which urges policies which work and not those which simply play to the gallery."
The comments came at the same time as a special edition of the BMJ in which the editor, Fiona Godlee, endorses an article by Steve Rolles of Transform, a group which lobbies for reform of the UK's drugs laws.
The chair of the Bar Council argued in his most recent report that decriminalising drug use would have substantial public benefits, while the editor of the British Medical Journal (BMJ), the UK's most well-respected medical publication, came out publicly in support of drug law reform.
The twin developments come at an exciting time for those calling for a more liberal drug policy. Both deputy prime minister Nick Clegg and prime minister David Cameron are on record questioning the effectiveness of Britain's drug laws. Activists hope reform might be in the pipeline.
In his most recent report the chair of the Bar Council, Nicholas Green QC, argued that decriminalising drugs did not lead to greater use and would have the effect of cutting crime.
"A growing body of comparative evidence suggests that decriminalising personal use can have positive consequences; it can free up huge amounts of police resources, reduce crime and recidivism and improve public health," he said.
"All this can be achieved without any overall increase in drug usage. If this is so, then it would be rational to follow suit. And this will save money and mean that there is less pressure on the justice system.
"A rational approach is not usually the response of large parts of the media when it comes to issues relating to criminal justice," he continued.
"This is something the Bar Council can address. We are apolitical; we act for the prosecution and the defence and most of the judiciary are former members. We can speak out in favour of an approach which urges policies which work and not those which simply play to the gallery."
The comments came at the same time as a special edition of the BMJ in which the editor, Fiona Godlee, endorses an article by Steve Rolles of Transform, a group which lobbies for reform of the UK's drugs laws.